Candida sp in the oral cavity with and without lesions: maximal inhibitory dilution of Propolis and Periogard

Detalhes bibliográficos
Autor(a) principal: Azevedo,Rosa Vitória Palamin
Data de Publicação: 1999
Outros Autores: Komesu,Marilena Chinalli, Candido,Regina Celia, Salvetti,Cristiane, Rezende,Fausto Hanaoka Caetano
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista de Microbiologia
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37141999000400008
Resumo: Fifty individuals of both sexes aged on average 45.2 years were evaluated at the Semiology Clinic of FORP-USP in order to isolate and identify yeasts from the oral cavity, with and without lesions, and to determine the maximal inhibitory dilution (MID) of the commercial products Propolis (Apis-Flora) and Periogard (Colgate) against the strains isolated. Yeasts of the genus Candida were detected in the saliva of 9/19 (47.4%) individuals with a clinically healthy mouth, 18/22 (81.8%) of individuals with oral lesions, and in 4/9 (44.4%) of patients with deviation from normality, and were detected in 19/22 (86.4%) of the lesions. In the group with oral candidiasis, we isolated in tongue and lesion, respectively for each specie: C.tropicalis (8% and 10.7%), C.glabrata (4% and 3.6%) and C.parapsilosis (2% and 3.6%), in addition to C.albicans (71.4% and 67.8%) as the only species and the prevalent. The total cfu counts/ml saliva showed a higher mean value in the group with oral candidiasis (171.5% x 10(3)) than in the control group (72.6 x 10(3)) or the group with abnormalities (8.3 x 10(3)). Most of the test strains 67/70 (95.71%) were sensitive to the antiseptics, with Propolis presenting a MID of 1:20 for 54/70/77.1%), and Periogard a MID of 1:160 for 42/70 (60%) strains from healthy sites, results similar to those obtained with strains from oral lesions. Different results were mainly observed among different species. The results indicate the possibility of using the antiseptics Propolis and Periogard (chlorhexidine) for the prevention and treatment of oral candidiasis.
id SBM-2_fc9eb8dc3de30c0d96c0b2e80cc3179d
oai_identifier_str oai:scielo:S0001-37141999000400008
network_acronym_str SBM-2
network_name_str Revista de Microbiologia
repository_id_str
spelling Candida sp in the oral cavity with and without lesions: maximal inhibitory dilution of Propolis and PeriogardOral candidiasisPropolischlorhexidineyeastsFifty individuals of both sexes aged on average 45.2 years were evaluated at the Semiology Clinic of FORP-USP in order to isolate and identify yeasts from the oral cavity, with and without lesions, and to determine the maximal inhibitory dilution (MID) of the commercial products Propolis (Apis-Flora) and Periogard (Colgate) against the strains isolated. Yeasts of the genus Candida were detected in the saliva of 9/19 (47.4%) individuals with a clinically healthy mouth, 18/22 (81.8%) of individuals with oral lesions, and in 4/9 (44.4%) of patients with deviation from normality, and were detected in 19/22 (86.4%) of the lesions. In the group with oral candidiasis, we isolated in tongue and lesion, respectively for each specie: C.tropicalis (8% and 10.7%), C.glabrata (4% and 3.6%) and C.parapsilosis (2% and 3.6%), in addition to C.albicans (71.4% and 67.8%) as the only species and the prevalent. The total cfu counts/ml saliva showed a higher mean value in the group with oral candidiasis (171.5% x 10(3)) than in the control group (72.6 x 10(3)) or the group with abnormalities (8.3 x 10(3)). Most of the test strains 67/70 (95.71%) were sensitive to the antiseptics, with Propolis presenting a MID of 1:20 for 54/70/77.1%), and Periogard a MID of 1:160 for 42/70 (60%) strains from healthy sites, results similar to those obtained with strains from oral lesions. Different results were mainly observed among different species. The results indicate the possibility of using the antiseptics Propolis and Periogard (chlorhexidine) for the prevention and treatment of oral candidiasis.Sociedade Brasileira de Microbiologia1999-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37141999000400008Revista de Microbiologia v.30 n.4 1999reponame:Revista de Microbiologiainstname:Sociedade Brasileira de Microbiologia (SBM)instacron:SBM10.1590/S0001-37141999000400008info:eu-repo/semantics/openAccessAzevedo,Rosa Vitória PalaminKomesu,Marilena ChinalliCandido,Regina CeliaSalvetti,CristianeRezende,Fausto Hanaoka Caetanoeng2000-04-19T00:00:00Zoai:scielo:S0001-37141999000400008Revistahttps://www.scielo.br/j/rm/ONGhttps://old.scielo.br/oai/scielo-oai.phpbjm@sbmicrobiologia.org.br||revmicro@icb.usp.br0001-37140001-3714opendoar:2000-04-19T00:00Revista de Microbiologia - Sociedade Brasileira de Microbiologia (SBM)false
dc.title.none.fl_str_mv Candida sp in the oral cavity with and without lesions: maximal inhibitory dilution of Propolis and Periogard
title Candida sp in the oral cavity with and without lesions: maximal inhibitory dilution of Propolis and Periogard
spellingShingle Candida sp in the oral cavity with and without lesions: maximal inhibitory dilution of Propolis and Periogard
Azevedo,Rosa Vitória Palamin
Oral candidiasis
Propolis
chlorhexidine
yeasts
title_short Candida sp in the oral cavity with and without lesions: maximal inhibitory dilution of Propolis and Periogard
title_full Candida sp in the oral cavity with and without lesions: maximal inhibitory dilution of Propolis and Periogard
title_fullStr Candida sp in the oral cavity with and without lesions: maximal inhibitory dilution of Propolis and Periogard
title_full_unstemmed Candida sp in the oral cavity with and without lesions: maximal inhibitory dilution of Propolis and Periogard
title_sort Candida sp in the oral cavity with and without lesions: maximal inhibitory dilution of Propolis and Periogard
author Azevedo,Rosa Vitória Palamin
author_facet Azevedo,Rosa Vitória Palamin
Komesu,Marilena Chinalli
Candido,Regina Celia
Salvetti,Cristiane
Rezende,Fausto Hanaoka Caetano
author_role author
author2 Komesu,Marilena Chinalli
Candido,Regina Celia
Salvetti,Cristiane
Rezende,Fausto Hanaoka Caetano
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Azevedo,Rosa Vitória Palamin
Komesu,Marilena Chinalli
Candido,Regina Celia
Salvetti,Cristiane
Rezende,Fausto Hanaoka Caetano
dc.subject.por.fl_str_mv Oral candidiasis
Propolis
chlorhexidine
yeasts
topic Oral candidiasis
Propolis
chlorhexidine
yeasts
description Fifty individuals of both sexes aged on average 45.2 years were evaluated at the Semiology Clinic of FORP-USP in order to isolate and identify yeasts from the oral cavity, with and without lesions, and to determine the maximal inhibitory dilution (MID) of the commercial products Propolis (Apis-Flora) and Periogard (Colgate) against the strains isolated. Yeasts of the genus Candida were detected in the saliva of 9/19 (47.4%) individuals with a clinically healthy mouth, 18/22 (81.8%) of individuals with oral lesions, and in 4/9 (44.4%) of patients with deviation from normality, and were detected in 19/22 (86.4%) of the lesions. In the group with oral candidiasis, we isolated in tongue and lesion, respectively for each specie: C.tropicalis (8% and 10.7%), C.glabrata (4% and 3.6%) and C.parapsilosis (2% and 3.6%), in addition to C.albicans (71.4% and 67.8%) as the only species and the prevalent. The total cfu counts/ml saliva showed a higher mean value in the group with oral candidiasis (171.5% x 10(3)) than in the control group (72.6 x 10(3)) or the group with abnormalities (8.3 x 10(3)). Most of the test strains 67/70 (95.71%) were sensitive to the antiseptics, with Propolis presenting a MID of 1:20 for 54/70/77.1%), and Periogard a MID of 1:160 for 42/70 (60%) strains from healthy sites, results similar to those obtained with strains from oral lesions. Different results were mainly observed among different species. The results indicate the possibility of using the antiseptics Propolis and Periogard (chlorhexidine) for the prevention and treatment of oral candidiasis.
publishDate 1999
dc.date.none.fl_str_mv 1999-12-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37141999000400008
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37141999000400008
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0001-37141999000400008
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Microbiologia
publisher.none.fl_str_mv Sociedade Brasileira de Microbiologia
dc.source.none.fl_str_mv Revista de Microbiologia v.30 n.4 1999
reponame:Revista de Microbiologia
instname:Sociedade Brasileira de Microbiologia (SBM)
instacron:SBM
instname_str Sociedade Brasileira de Microbiologia (SBM)
instacron_str SBM
institution SBM
reponame_str Revista de Microbiologia
collection Revista de Microbiologia
repository.name.fl_str_mv Revista de Microbiologia - Sociedade Brasileira de Microbiologia (SBM)
repository.mail.fl_str_mv bjm@sbmicrobiologia.org.br||revmicro@icb.usp.br
_version_ 1754821030228000768